Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by BayStreetWildon Mar 02, 2023 7:48pm
64 Views
Post# 35316443

RE:RE:RE:RE:Hospitals don’t want to do trials anymore..

RE:RE:RE:RE:Hospitals don’t want to do trials anymore..

What facts do you need?


50 million dollars, 3-4 years, and 52 patients to show for it. 

800k a year in total ceo compensation. He's getting paid like he's running a major corporation and has the financial results of a local lemonade stand. 

You can go on glassdoor.com and look at what every person working for the company has said. (It's not pretty)

They consistently over promise and underdeliver. Most if not all investors think it's done intentionally.

Revenue is going down YOY

Lost control of Dialco

Mass departures from top management and best talent

Failed deadlines

Amory didn't stick around for more than a few months. Saw the writing on the wall reallllllyy quick. 

But pump on.
 

<< Previous
Bullboard Posts
Next >>